Carl Zeiss Meditec AG (XSWX:AFX) Other Operating Expense: CHF1 Mil (TTM As of Dec. 2025)


XSWX:AFX Carl Zeiss Meditec AG XSWX:AFX
67 GF Score
Price CHF25.86
GF Value CHF65.76
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Other Operating Expense?

Carl Zeiss Meditec AG XSWX:AFX +2.54% 67 Other Operating Expense is CHF1 Mil as of Dec. 2025. GuruFocus rates XSWX:AFX with a GF Score™ of 67/100 and a GF Value™ of CHF65.76 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Carl Zeiss Meditec AG's Other Operating Expense for the three months ended in Dec. 2025 was CHF0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was CHF1 Mil.

Carl Zeiss Meditec AG's quarterly Other Operating Expense declined from Jun. 2025 (CHF1 Mil) to Sep. 2025 (CHF-1 Mil) but then increased from Sep. 2025 (CHF-1 Mil) to Dec. 2025 (CHF0 Mil).

Carl Zeiss Meditec AG's annual Other Operating Expense declined from Sep. 2023 (CHF4 Mil) to Sep. 2024 (CHF-17 Mil) but then increased from Sep. 2024 (CHF-17 Mil) to Sep. 2025 (CHF-1 Mil).

Carl Zeiss Meditec AG Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG Other Operating Expense Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.66 1.25 4.13 -17.04 -0.86

Carl Zeiss Meditec AG Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.96 1.05 0.80 -0.76 0.00
XSWX:AFX
67GF Score
Carl Zeiss Meditec AG XSWX:AFX
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of CHF1 Mil mean?
Carl Zeiss Meditec AG (XSWX:AFX) has a Other Operating Expense of CHF1 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Carl Zeiss Meditec AG and its competitors.
Is Carl Zeiss Meditec AG's Other Operating Expense too high?
Carl Zeiss Meditec AG's current Other Operating Expense is CHF1 Mil. Overall, Carl Zeiss Meditec AG has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Other Operating Expense compare to ISRG and BDX?
Carl Zeiss Meditec AG's Other Operating Expense of CHF1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Carl Zeiss Meditec AG and its competitors. Carl Zeiss Meditec AG's current Other Operating Expense is CHF1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (XSWX:AFX) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF65.76, compared to a current price of CHF25.86 — trading 60.7% below its estimated fair value. The current Other Operating Expense is CHF1 Mil. Carl Zeiss Meditec AG's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current Other Operating Expense is CHF1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of CHF25.86 is trading 60.7% below its estimated GF Value™ of CHF65.76. GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.

Key valuation signals for XSWX:AFX:

  • Other Operating Expense: CHF1 Mil
  • GF Value™: CHF65.76 vs. price of CHF25.86 (60.7% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
67GF Score

Get the complete analysis for XSWX:AFX

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF25.86
Price
CHF65.76
GF Value